Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06473896
NA

Effect of Ketalar or Dexmedetomidine on Increased Sensitivity to Pain Following Treatment With Remifentanil

Sponsor: Assaf-Harofeh Medical Center

View on ClinicalTrials.gov

Summary

Analgesia is one of the pillars of anesthesia. One of the common opiates for pain relief, with a short half-life, is Remifentanil. However, following Remifentanil treatment an increased sensitivity to pain \[hyperalgesia\] appears. The aim of the study is to compare the effects between complementary treatments, like Ketalar and Dexmedetomidine, in preventing increased sensitivity to pain after Remifentanil treatment

Official title: Comparison of the Effect of Ketalar or Dexmedetomidine on Increased Sensitivity to Pain Induced Following Treatment With Remifentanil in Patients Undergoing a Laparoscopic Cholecystectomy

Key Details

Gender

All

Age Range

18 Years - 85 Years

Study Type

INTERVENTIONAL

Enrollment

90

Start Date

2024-04-18

Completion Date

2026-08-30

Last Updated

2024-08-07

Healthy Volunteers

No

Conditions

Interventions

DRUG

Ketalar

a dissociative anesthetic used medically for induction and maintenance of anesthesia

DRUG

Dexmedetomidine

an agonist of α2-adrenergic receptors in certain parts of the brain used for sedation

Locations (1)

Shamir (Asaf Harofe) Medical Center

Be’er Ya‘aqov, Israel